光动力疗法治疗非黑色素瘤皮肤癌的研究进展

doi:10.11904/j.issn.1002-3070.2016.01.015

Abstract

Abstract:

Non-melanoma skin cancers(NMSC)are one of the most common malignancy in humans.Among NMSC types,basal cell carcinoma(BCC)has the highest incidence and squamous cell carcinoma(SCC)is less common although it can metastasize.Over 30 years ago,Photodynamic therapy(PDT)was applied for the study of human tumor,it showed the advantage of being a non-invasive option,and capable of field treatment,providing optimum cosmetic outcomes.Numerous clinical research studies have shown the efficacy of PDT for treating NMSC.The purpose of this systematic review is to summarize the previous Results,current evidence and the possibilities for PDT in patients with NMSC.

Key words: Photodynamic therapy, Non-melanoma skin cancer, Basal cell carcinoma, Squamous cell carcinoma

CLC Number:

R730.59

ZHANG Jiahui, BI Liangjia. Research advances in the treatment of non-melanoma skin cancer using photodynamic therapy[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(1): 71-74.

References

1 Eisemann N,Waldmann A,Geller AC,et al.Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence[J].Investig Dermatol,2014,134(1):43-50.
2 Koyuncuer A.Histopathological evaluation of non-melanoma skin cancer[J].World J Surg Oncol,2014,12(12):159-165.
3 Berking C,Hauschild A,Klbl O,et al.Basal cell carcinoma-treatments for the commonest skin cancer[J].Dtsch Arztebl Int,2014,111(22):389-395.
4 Martorell-Calatayud A,Sanmartín O,Cruz J,et al.Cutaneous squamous cell carcinoma:Defining the high-risk variant[J].Actas Dermosifiliogr,2013,104(5):367-379.
5 Mfouo-Tynga I,Abrahamse H.Cell death pathways and phthalocyanine as an efficient agent for photodynamic cancer therapy[J].Int J Mol Sci,2015,16(5):10228-10241.
6 Morton C,Szeimies RM,Sidoroff A,et al.European Dermatology Forum Guidelines on topical photodynamic therapy[J].Eur J Dermatol,2015,25(4):296-311.
7 Kauvar AN,Cronin T,Jr Roenigk R,et al.Consensus for nonmelanoma skin cancer treatment:Basal cell carcinoma,including a cost analysis of treatment methods[J].Dermatol Surg,2015,41(5):550-571.
8 Ferrándiz C,Fonseca-Capdevila E,García-Diez A,et al.Spanish adaptation of the European guidelines for the evaluation and treatment of actinic keratosis[J].Actas Dermosifiliogr,2014,105(4):378-393.
9 Steinbauer JM,Schreml S,Kohl EA,et al.Photodynamic therapy in dermatology[J].Dtsch Dermatol Ges,2010,8(6):454-464.
10 Choudhary S,Nouri K,Elsaie ML,et al.Photodynamic therapy in dermatology:A review[J].Lasers Med Sci,2009,24(6):971-980.
11 Blume JE,Oseroff AR.Aminolevulinic acid photodynamic therapy for skin cancers[J].Dermatol Clin,2007,25(1):5-14.
12 Evangelou G,Farrar MD,Cotterell L,et al.Topical photodynamic therapy significantly reduces epidermal Langerhans cells during clinical treatment of basal cell carcinoma[J].Br J Dermatol,2012,166(5):1112-1115.
13 Lu YG,Wang YY,Yang YD,et al.Efficacy of topical ALA-PDT combined with excision in the treatment of skin malignant tumor[J].Photodiagn Ther,2014,11(2):122-126.
14 Jeremic G,Brandt MG,Jordan K,et al.Using photodynamic therapy as a neoadjuvant treatment in the surgical excision of nonmelanotic skin cancers:Prospective study[J].Otolaryngol Head Neck Surg,2011,40(1):82-89.
15 Sotiriou E,Lallas A,Apalla Z,et al.Treatment of giant Bowen′s disease with sequential use of photodynamic therapy and imiquimod cream[J].Photodermatol Photoimmunol Photomed,2011,27(3):164-166.
16 Cai H,Wang YX,Zheng JC,et al.Photodynamic therapy in combination with CO₂ laser for the treatment of Bowen′s disease[J].Lasers Med Sci,2015,30(5):1505-1510.
17 Rollakanti K,Anand S,Maytin EV,et al.Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models[J].Proc SPIE Int Soc Opt Eng,2015,2(2):1-13.
18 Torres T,Fernandes I,Costa V,et al.Photodynamic therapy as adjunctive therapy for morpheaform basal cell carcinoma[J].Acta Dermatovenerol Alp Pannonica Adriat,2011,20(1):23-25.
19 Osiecka B,Jurczyszyn K,Ziólkowski P,et al.The application of Levulan-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma[J].Med Sci Monit,2012,18(2):5-9.
20 Requena C,Messeguer F,Llombart B,et al.Facial extensive recurrent basal cell carcinoma:Successful treatment with photodynamic therapy and imiquimod 5% cream[J].Int J Dermatol,2012,51(4):451-454.
21 Smucler R,Vlk M.Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma[J].Lasers Surg Med,2008,40(2):153-158.
22 Shokrollahi K,Javed M,Aeuyung K,et al.Combined carbon dioxide laser with photodynamic therapy for nodular and superficial basal cell carcinoma[J].Ann Plast Surg,2014,73(5):552-558.
23 Kasche A,Luderschmidt S,Ring J,et al.Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid[J].J Drugs Dermatol,2006,5(4):353-356.
24 Morton CA,Szeimies RM,Sidoroff A,et al.European guidelines for topical photodynamic therapy part 1:Treatment delivery and current indications-actinic keratoses,Bowen′s disease,basal cell carcinoma[J].J Eur Acad Dermatol Venereol,2013,27(5):536-544.
25 Braathen LR,Szeimies RM,Basset-Seguin N,et al.Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer:An international consensus[J].Am Acad Dermatol,2007,56(1):125-143.
26 Roozeboom MH,van Kleef L,Arits AH,et al.Tumor thickness and adnexal extension of superficial basal cell carcinoma(sBCC)as determinants of treatment failure for methyl aminolevulinate(MAL)-photodynamic therapy(PDT),imiquimod,and 5-fluorouracil(FU)[J].Am Acad Dermatol,2015,73(1):93-98.
27 Christensen E,Mrk C,Foss OA,et al.Pre-treatment deep curettage can significantly reduce tumour thickness in thick basal cell carcinoma while maintaining a favourable cosmetic outcome when used in combination with topical photodynamic therapy[J].Skin Cancer,2011,240(6):1-6.
28 Nissen CV,Philipsen PA,Wulf HC,et al.PpIX formation after topical application of methyl aminolevulinate and BF-200 ALA declines with age[J].Br J Dermatol,2015,173(3):760-766.
29 Vinciullo C,Elliott T,Francis D,et al.Photodynamic therapy with topical methyl aminolaevulinate for “difficult-to-treat” basal cell carcinoma[J].Br J Dermatol,2005,152(4):765-772.

[1]	WANG Lei, JIANG Huanyu, SONG Kaibin. miR-219 regulates PRKCI expression in tongue squamous cell carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 510-514.
[2]	HAO He,LI Xing,WU Lingyan,GUO Xiaojin,CAO Jing,YANG Chunwang,ZHANG Xiao,WANG Zhiyu. Expression of PD-1,CTLA-4 and BLTA in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical implications [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 303-308.
[3]	LI Hongwei,JIANG Xiaofeng,CHEN Song,BIE Yifei,DU Yong. A case of huge scar squamous cell carcinoma with skull and dural invasion [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 337-339.
[4]	DU Lingbin,WEI Wenqiang. Progress research in survival analysis of esophageal squamous cell carcinoma(ESCC)in Chinese population [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 344-348.
[5]	ZHOU Jie, CHEN Yu, CHEN Daozhen. Application of nanoparticles in photodynamic therapy of tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 245-249.
[6]	XU Wenpin, JIAO Kun, ZHANG Wei. Research progress of Long non-coding RNAs in oral squamous cell carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 258-262.
[7]	DUAN Yanjun, XU Wei, CHEN Wenjie, WANG Fengjuan. Effects of Wnt pathway inhibitor ETC-159 on proliferation and migration of OSCC cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 103-106.
[8]	LI Hongwei, LIU Chuan, WANG Lang, LIU Jun, YANG Hanfeng, DU Yong. Research progress of photodynamic therapy in malignant tumor of digestive tract [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 77-81.
[9]	ZHOU Shixiang,LI Duojie. The research advances of zinc transporter LIV-1 in esophageal squamous cell carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(6): 572-576.
[10]	ZHOU Junmin, DAI Shaochun, ZHOU Sen. Effect of 5-aminolevulinic acid mediated photodynamic therapy in combination with recombinant human interferon alpha 2b ointment on basal cell carcinoma in elderly [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(5): 396-399.
[11]	YUAN Zhennan, SONG Kaibin. Expression and significance of miR-219 in tongue squamous cell carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(5): 420-424.
[12]	JI Xueyu,ZANG Lixin,WANG Yueping,MENG Peisong. Study of cell killing effect of aloe-emodin mediated photodynamic therapy on KB cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(3): 220-224.
[13]	LIU Bingmei, XIA Lijie, LIU Yimei, YANG Jing. Advance research on cutaneous squamous cell carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(6): 545-548.
[14]	LIU Yanan,CHEN Lina,ZHANG Jing,ZHOU Yongfang,LI Xiaoli. Expressions and clinical significances of IGF-1R and IRS-1 in squamous cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(3): 225-230.
[15]	LIU Bingmei,YANG Jing,ZHANG Hanwen,XING Ronggui,LI Lili,ZHAO Liping,QIAO Shi,YOU Haiyan. The research on expression of cell cycle and apoptosis related protein in keratoacanthoma and well-differentiated squamous cell carcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2014, 28(6): 485-491.

Research advances in the treatment of non-melanoma skin cancer using photodynamic therapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments